share_log

Akero Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alkeon Capital Management LLC(4.8%),Panayotis D. Sparaggis(4.8%)

Akero Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Alkeon Capital Management LLC(4.8%),Panayotis D. Sparaggis(4.8%)

美股SEC公告 ·  2024/11/13 22:47
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息